$25 can support one day of treatment on a clinical trial for a child with cancer. $50 can fund ten minutes of Acceleration Initiative research, like research conducted on Ewing sarcoma.
Cancer Research for Children - CureSearch
More than 15,000 children are diagnosed with cancer annually. To save their child’s life, parents often have to consent to toxic therapies, knowing debilitating side effects are likely to follow their child throughout his or her life.
For over 30 years, CureSearch for Children’s Cancer has been a driving force behind the development of better, less-toxic treatments for every child diagnosed with cancer. We fund high potential research focused on moving new treatments quickly to the clinic and ultimately, to the children who depend on us. We also provide families with the resources and support they need to navigate a cancer diagnosis, and our nationwide fundraising events bring communities together in support of our shared mission to end children’s cancer.
Our mission is to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame.
Improve childhood cancer treatment and cures to deliver the potential for childhood cancer patients to lead long, healthy lives.
At CureSearch, we support researchers through funding, but also the guidance, knowledge and relationships to navigate the regulatory environment and clinical trials network to ensure the greatest chance of success.
OUR IMPACT ON FAMILIES AND COMMUNITIES More than one million families have connected to curesearch.org for instantly available resources, tools and information about children's cancer. Additionally, CureSearch hosts events around the nation that bring together communities to celebrate and honor children affected by cancer.
The Young Investigator portfolio provides seed funding for bright researchers, early in their careers, pursuing exciting novel ideas. Early-career investigators are the most vulnerable to federal funding shortages, and they rely heavily on the support of private foundations like CureSearch to continue their research.
The Acceleration Initiative program addresses the largest obstacles in children’s cancer research, driving translational research into the clinic.
The Catapult Awards advance the strongest research into clinical trials and ultimately drug development. By funding Phase I or Phase II clinical research, we are driving new treatments to the marketplace, quickly.
CureSearch won’t stop until more and better children’s cancer treatments are out of the lab and into the clinic and marketplace, ensuring more children live long, healthy and productive lives.
Learn more at curesearch.org.